Related Experiment Video
Updated: Jun 27, 2026
Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
An evaluation of cyclooxygenase-1 inhibition before coronary artery surgery: aggregometry versus patient
Niels Rahe-Meyer1, Michael Winterhalter, Julia Hartmann
1Department of Anesthesiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. rahe-meyer.niels@mh-hannover.de
Insights
Assessing platelet function, not just patient self-reporting of aspirin intake, better predicts perioperative bleeding and transfusion needs. Measuring platelet aggregation identifies patients requiring more platelet transfusions.
Area of Science:
- Cardiology
- Hematology
- Anesthesiology
Background:
- Antiplatelet therapy, like aspirin, can cause platelet dysfunction, increasing perioperative bleeding risks.
- Previous studies on aspirin intake before surgery yielded conflicting results regarding transfusion needs.
Purpose of the Study:
- To compare patient self-reporting of aspirin intake with platelet function tests in predicting transfusion requirements.
- To evaluate the efficacy of arachidonic acid-induced platelet aggregation as a predictor of perioperative coagulopathy.
Main Methods:
- A prospective trial involving 100 patients undergoing coronary artery bypass grafting.
- Aspirin intake was assessed via questionnaire, and platelet aggregation was measured using the Multiplate analyzer with arachidonic acid.
- Chest tube drainage and red blood cell transfusions were monitored postoperatively.
Main Results:
- Patient self-reporting of aspirin intake did not correlate with transfusion requirements or bleeding.
- Abnormal platelet aggregation, but not reported aspirin use, was linked to increased platelet transfusions (1.1 U vs. 0.3 U).
- No significant differences in chest tube drainage were observed between groups based on reported aspirin intake or aggregation response.
Conclusions:
- Arachidonic acid-induced platelet aggregation is a more reliable predictor of platelet-related coagulopathy and transfusion needs than patient self-reporting of aspirin intake.
- Platelet function testing can guide perioperative management and transfusion strategies more effectively.
Background:
Platelet dysfunction due to antiplatelet therapy contributes to perioperative bleeding. Several trials investigating the influence of aspirin intake within the 5 days before surgery reported that transfusion requirements were either increased or not significantly affected by aspirin intake. Our objective was to compare the assessment of aspirin intake by patient self-reporting and by measurement of platelet function with regard to transfusion requirements.
Methods:
In a prospective trial, a standardized questionnaire was used in 100 patients for aspirin intake within the 5 days immediately before coronary artery bypass grafting. Whole blood platelet aggregation triggered by arachidonic acid was investigated using the Multiplate platelet function analyzer.
Results:
Eleven of 23 patients with aspirin intake within the 5 days before the intervention showed an abnormal aggregation response. Nine of 77 patients who reported no aspirin intake before surgery had an abnormal aggregation response. There were no significant differences in chest tube drainage and red blood cell transfusion over the first 24 h postoperatively between patients with and without reported aspirin intake. There was no significant difference in chest tube drainage over the first 24 h postoperatively between patients showing normal or abnormal aggregation response. Patients with abnormal aggregation before intervention (<51 U) received significantly more platelet transfusion than patients with normal aggregation (1.1 U compared to 0.3 U, P = 0.001).
Conclusions:
Our results suggest that arachidonic acid-induced aggregation in whole blood may be a better predictor of platelet-related coagulopathy and platelet transfusion than the assessment of aspirin intake by patient self-reporting.
